Inventor · disambiguated record
Richard Danger
Also filed as: DANGER RICHARD
6 granted patents·2 pending applications·1 citations·filing 2015–2024
66Inventor score
Files withINST NAT SANTE RECH MED4OSE IMMUNOTHERAPEUTICS2CT HOSPITALIER UNIVERSITAIRE NANTES1INSERM INSTITUTE NATIONAL DE LA SANTE ET DE LA RECH MEDICALE1
Top patents by PatentIndex Score
8 records- 0177US2024384349A1Biomarkers for assessing the response status for treatment of inflammatory condition or disease affecting the digestive tract such as inflammatory bowel disease in human patientsOSE IMMUNOTHERAPEUTICS·Filed 2024·Application pending·0 cites
- 0276US10975438B2Methods and compositions for predicting chronic lung allograft dysfunctionINST NAT SANTE RECH MED·Filed 2017·Granted Apr 13, 2021·1 cites·7 claims
- 0364US11814683B2Methods and compositions for predicting chronic lung allograft dysfunctionINST NAT SANTE RECH MED·Filed 2021·Granted Nov 14, 2023·0 cites·7 claims
- 0460US12077820B2Biomarkers for assessing the response status for treatment of Inflammatory condition or disease affecting the digestive tract such as inflammatory bowel disease in human patientsOSE IMMUNOTHERAPEUTICS·Filed 2018·Granted Sep 3, 2024·0 cites·9 claims
- 0552US2024240254A1Non-invasive diagnosis of subclinical rejectionCT HOSPITALIER UNIVERSITAIRE NANTES·Filed 2022·Application pending·0 cites
- 0645US11421277B2Methods and compositions for predicting chronic lung allograft dysfunctionINSERM INSTITUTE NATIONAL DE LA SANTE ET DE LA RECH MEDICALE·Filed 2018·Granted Aug 23, 2022·0 cites·5 claims
- 0739US10961580B2Methods for predicting graft alterationsINST NAT SANTE RECH MED·Filed 2015·Granted Mar 30, 2021·0 cites·8 claims
- 0836US11479817B2Methods for discriminating a tolerant subjectINST NAT SANTE RECH MED·Filed 2017·Granted Oct 25, 2022·0 cites·10 claims
Join the waitlist — get patent alerts
Get an alert when Richard Danger files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →